Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Sex-linked Disorders01:43

Sex-linked Disorders

108.1K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
108.1K
Genetic Lingo01:11

Genetic Lingo

113.5K
Overview
113.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

931
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
931
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

736
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
736

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prescribing Pattern of Antiseizure Drugs in Pediatric Epilepsy Patients at a Tertiary Care Hospital in New Delhi: A Cross-Sectional Study.

Cureus·2026
Same author

Parental autistic traits and neurodevelopmental outcomes in children with autism spectrum disorder: a family phenotype perspective.

Developmental neurorehabilitation·2026
Same author

From Diagnosis to Recovery: Charting the Path of Children With Chronic Inflammatory Demyelinating Polyneuropathy in a Tertiary Care Setting.

Journal of child neurology·2026
Same author

Traditional Blowpipe (Phukne) Use as a Risk Factor for Pediatric Inhalation Injury in the Himalayas.

Indian journal of pediatrics·2026
Same author

Validation of the Hindi version of Trivandrum Development Screening Chart (TDSC) as a Developmental Screening Tool in Children aged 1-30 Months.

Indian pediatrics·2025
Same author

General Pediatrics.

Indian pediatrics·2025

Related Experiment Video

Updated: Jan 7, 2026

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

3.0K

Navigating the Uncommon: "Juvenile-Onset Huntington Disease".

Anmol Aatli1, Smriti Saryan1, Rachna Sehgal1

  • 1Department of Pediatrics, VMMC & Safdarjung Hospital, New Delhi, India.

Journal of Child Neurology
|December 19, 2025
PubMed
Summary

Diagnosing rare neurodegenerative disorders in children is difficult. Genetic evaluation identified a rare condition in a pediatric patient presenting with stroke, cognitive decline, and movement disorders.

Keywords:
antiepileptic drugscognitiondevelopmental disabilitydystoniaepileptic encephalopathygeneticsleukodystrophyneurodevelopmentnext-generation sequencingrefractory

More Related Videos

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

10.0K
Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

8.4K

Related Experiment Videos

Last Updated: Jan 7, 2026

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

3.0K
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

10.0K
Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

8.4K

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Progressive neurodegeneration with movement disorders presents diagnostic challenges.
  • A 12-year-old female experienced stroke, neurocognitive decline, choreo-athetoid movements, dystonia, and epilepsy.

Purpose of the Study:

  • To present a case of a rare neurodegenerative condition in a pediatric patient.
  • To discuss diagnostic and management challenges, including the role of genetic evaluation and surgical interventions.

Main Methods:

  • Clinical case presentation.
  • Neuroimaging (implied by cortical involvement).
  • Genetic evaluation.
  • Discussion of management strategies, including surgical options for dystonia.

Main Results:

  • A rare neurodegenerative condition was diagnosed via genetic evaluation despite no significant family history.
  • The patient exhibited diffuse cortical involvement, impacting speech and bladder/bowel control.
  • Worsening dystonia and epilepsy were noted.

Conclusions:

  • Genetic evaluation is crucial for diagnosing rare neurodegenerative disorders in children.
  • Management requires a multidisciplinary approach, addressing neurological deficits and movement disorders.
  • Surgical intervention may be necessary for refractory dystonia in pediatric cases.